trending Market Intelligence /marketintelligence/en/news-insights/trending/fu0uaxjgdtd2vijgmuoncq2 content esgSubNav
In This List

AmpliPhi Biosciences plans $3M common stock offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


AmpliPhi Biosciences plans $3M common stock offering

San Diego-based AmpliPhi Biosciences Corp. agreed to sell 2,743,640 common shares at $1.10 per share in an offering to certain institutional investors.

The company, which develops therapies for infections, expects gross proceeds of about $3 million. AmpliPhi plans to use the net proceeds for general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent for the offering, which is expected to close by March 22.